12. Valvular heart diseases, Echocardiography.
Valvular heart disease encompasses a range of disorders that impair the function of the heart valves, leading to stenosis (narrowing of the valve opening), insufficiency (inability of the valve to close properly), or both. This disease predominantly affects the aortic and mitral valves, though the tricuspid valve can also be involved typically in intravenous drug users, and defects in the pulmonary valve are usually seen with congenital conditions.
Aortic Valve Stenosis
Aortic valve stenosis is the most prevalent valvular condition in developed nations, affecting up to 12% of the population, though many of these cases remain asymptomatic until the disease progresses. The risk of developing aortic valve stenosis increases with age and is often accompanied by aortic regurgitation.
Aetiology of Aortic Valve Stenosis:
Aortic Valve Sclerosis:
This is the most common cause and involves the fibrosis and calcification of the aortic valve leaflets. The process is similar to atherosclerosis and is associated with risk factors such as dyslipidemia, diabetes, and hypertension.
Bicuspid Aortic Valve:
This is the most frequent congenital malformation of the heart valves, occurring three times more often in males. In this condition, the aortic valve has two cusps instead of the normal three. This anatomical anomaly makes the valve susceptible to early degeneration and calcification, leading to earlier onset and more rapid progression of stenosis compared to individuals with normal aortic valves.
Rheumatic Fever:
Although now rare in developed countries due to effective antibiotic treatment of streptococcal infections, rheumatic fever can lead to severe valvular heart disease. It causes the fusion of the valve commissures, predominantly affecting the aortic and mitral valves. This fusion leads to both stenosis and regurgitation over time.
Pathophysiology of Aortic Valve Stenosis
In aortic valve stenosis, the pathophysiology revolves around the obstruction of blood flow due to the narrowing of the aortic valve. This creates several cascading effects on the heart and overall cardiovascular system:
Increased Afterload: The narrowing at the aortic valve increases the resistance against which the left ventricle must pump blood. This increases the afterload—the pressure that the heart must work against to eject blood during systole.
Concentric Hypertrophy of the Left Ventricle: To overcome the increased afterload, the left ventricle responds by thickening its walls—a process known as concentric hypertrophy. This adaptation helps to maintain stroke volume despite the increased pressure required to pump blood through the narrowed valve.
Impaired Ventricular Filling and Decreased Coronary Flow Reserve: As the ventricular walls thicken, the compliance (flexibility) of the left ventricle decreases, leading to impaired filling during diastole (the heart's relaxation phase). Since the coronary arteries fill during diastole, the shortening of this phase due to tachycardia (increased heart rate) further reduces the time for myocardial perfusion, exacerbating the risk of ischemia.
Increased Oxygen Demand: Hypertrophy increases the myocardial oxygen demand. This, combined with reduced coronary flow, heightens the risk of ischemic heart disease, as the heart muscle may not receive sufficient oxygen to meet its metabolic needs.
Progression to Heart Failure: Initially, the hypertrophied left ventricle can compensate and maintain adequate cardiac output through the Frank-Starling mechanism, which describes the increased stroke volume in response to increased ventricular filling (preload). However, as the disease progresses and hypertrophy continues, the myocardium’s contractility can diminish. Eventually, the left ventricle may fail, leading to a reduction in cardiac output and potential backward failure. This backward failure results in pulmonary congestion due to increased pressure in the left atrium and pulmonary veins.
Impact on the Right Heart: If left untreated, the increased pressure in the pulmonary circuit (pulmonary hypertension) from left heart failure imposes a higher load on the right ventricle, which can lead to right heart failure. This includes symptoms such as peripheral edema and ascites due to systemic venous congestion.
Law of Laplace: This law relates the wall tension in a spherical or cylindrical blood vessel to the pressure and radius of the vessel and the thickness of its wall. In the context of hypertrophy, although the wall thickness increases (potentially reducing tension), the radius of the ventricular chamber may also increase over time, especially if dilation occurs with progressive heart failure, potentially increasing wall tension again and exacerbating myocardial workload.
Clinical Features and Physical Examination of Aortic Valve Stenosis
In aortic valve stenosis, symptoms typically emerge when the stenosis becomes severe, usually when the valve area narrows to less than 1 cm² (normal valve area is 3-4 cm²) and the pressure gradient across the valve exceeds 40-50 mmHg. Below is a breakdown of the clinical features and physical examination findings associated with aortic valve stenosis:
Clinical Features of Aortic Valve Stenosis
Asymptomatic Phase: Many patients do not exhibit symptoms until the stenosis becomes severe. The condition can remain silent for years, only becoming symptomatic with significant narrowing.
Symptom Triad:
Angina Pectoris: As the myocardial mass increases due to left ventricular hypertrophy, the oxygen demand of the heart increases. Combined with a reduced coronary flow reserve, this can lead to myocardial ischemia.
Dyspnea: This is typically exertional and results from congestion in the pulmonary circulation due to impaired left ventricular function and elevated left atrial pressures.
Dizziness or Syncope: During physical exertion, peripheral vasodilation can cause a rapid drop in blood pressure. The stenotic aortic valve cannot increase output sufficiently to compensate, leading to reduced cerebral perfusion.
Prognosis: After the onset of symptoms, survival rates without surgical intervention are generally about 2-4 years, underscoring the condition's severity.
Physical Examination of Aortic Valve Stenosis
Blood Pressure: Characteristically shows a small pulse pressure (difference between systolic and diastolic pressures) due to the restricted output through the stenotic valve.
Pulse: The pulse may be weak and delayed ("pulsus parvus et tardus"), reflecting the slow and reduced stroke volume passing through the narrowed valve.
Palpable Systolic Thrill: This can be felt over the bifurcation of the carotids and the aorta, indicating turbulent flow through the stenotic valve.
Heart Sounds:
Systolic Ejection Murmur: Typically heard as a crescendo-decrescendo murmur, best audible in the 2nd right intercostal space, radiating to the carotids. The murmur's intensity decreases with maneuvers that increase afterload (e.g., handgrip) and decreases or remains unchanged with maneuvers that reduce preload (e.g., Valsalva maneuver, standing).
Soft S2: The aortic component of the second heart sound (A2) is softer and delayed due to the stenosis and the reduced speed of valve closure.
S4: A fourth heart sound is often present, best heard at the apex, indicating decreased compliance of the hypertrophied left ventricle.
Diagnostics of Aortic Valve Stenosis
ECG (Electrocardiogram): Typically shows non-specific signs, but may indicate left ventricular hypertrophy due to the increased strain on the heart from pumping blood through a narrowed valve.
Echocardiography: This is the primary diagnostic tool used to visualize the aortic valve's structure and function. It assesses the severity of stenosis, measures the velocity of blood flow through the valve using Doppler techniques, and evaluates the impact of the stenosis on heart function.
Chest X-ray: Useful for assessing signs of heart enlargement, pulmonary congestion, and the presence of calcifications on the aortic valve, indicative of severe stenosis.
Exercise or Dobutamine Stress Test: Helps to evaluate the heart's functioning under stress and can provoke symptoms to assess the severity of the condition.
Hemodynamic Cardiac Catheterization: Employed when non-invasive tests are inconclusive. This test directly measures the pressure across the aortic valve and the degree of obstruction.
Treatment of Aortic Valve Stenosis
Conservative Management: In cases of mild to moderate stenosis, patients are monitored regularly with echocardiography, advised to avoid strenuous activities, and given antibiotics prophylactically for endocarditis prevention.
Surgical Aortic Valve Replacement (AVR): This is recommended for symptomatic patients or those with severe stenosis and evidence of left ventricular dysfunction. The damaged valve is replaced with a mechanical or biological prosthesis:
Tissue Valves: Have limited durability (10-15 years) but require less aggressive anticoagulation (usually only aspirin).
Mechanical Valves: Offer longer durability but require lifelong anticoagulation with medications like warfarin, in addition to aspirin, to prevent thrombosis.
Transcatheter Aortic Valve Implantation (TAVI): Suitable for patients who are considered high-risk for surgical valve replacement. This less invasive procedure involves inserting a bioprosthetic valve via a catheter, typically through the femoral artery.
Balloon Aortic Valvuloplasty (BAV): Involves dilating the stenotic valve using a balloon catheter. It's generally a temporary solution or bridge to more definitive surgery, used particularly in high-risk patients, for palliation, or in younger patients who do not have significant calcification of the valve.
Complications of Aortic Valve Replacement (AVR):
Aortic valve replacement (AVR) is a surgical procedure to replace a diseased aortic valve, often due to conditions like aortic stenosis or aortic regurgitation. While AVR is typically a lifesaving intervention, it carries potential risks and complications:
Vascular Complications: Procedures such as transcatheter aortic valve replacement (TAVR) can cause complications related to vascular access, such as bleeding or vessel damage.
Thromboembolism and Stroke: Pieces of debris or blood clots can dislodge during or after the surgery, leading to blockages in the brain or other parts of the body.
Major Bleeding: The use of anticoagulants to prevent thrombosis and the invasive nature of the surgery can increase the risk of significant bleeding during or after the procedure.
Renal Failure: Decreased blood flow during surgery or contrast used during procedures like TAVR can impair kidney function, potentially leading to acute renal failure.
Arrhythmias: Surgical manipulation of the heart, especially the aortic region, can disrupt normal electrical pathways, leading to arrhythmias such as AV block or atrial fibrillation.
Aortic Regurgitation: In some cases, the new valve might not completely prevent backflow, especially if the valve becomes dysfunctional or is not perfectly fitted.
Endocarditis: Infection of the new valve, though rare, remains a serious complication that requires prompt antibiotic treatment and sometimes further surgical intervention.
AORTIC REGURGITATION
Aortic Regurgitation (AR) itself is a condition characterized by the backward flow of blood from the aorta into the left ventricle during diastole due to incomplete closure of the aortic valve. This condition can be acute or chronic, with different clinical manifestations and management strategies:
Acute Aortic Regurgitation
Causes:
Infective Endocarditis: Infection leading to damage of the aortic valve.
Aortic Dissection: A tear in the aorta that extends to involve the valve.
Chest Trauma: Direct injury to the valve or aortic root.
Pathophysiology:
Backflow of blood into the left ventricle increases its volume and pressure.
Rapid rise in left ventricular end-diastolic pressure leads to pulmonary congestion and edema.
Clinical Features:
Sudden Severe Dyspnea: Rapid onset of breathlessness due to pulmonary edema.
Pulmonary Edema: Fluid accumulation in the lungs, leading to breathing difficulties.
Cardiac Decompensation: The heart struggles to maintain adequate output, leading to hypotension and shock.
Fever: In cases of endocarditis.
Chest Pain: Particularly with aortic dissection
CHRONIC Aortic Regurgitation (AR):
Chronic aortic regurgitation involves the long-term backflow of blood from the aorta into the left ventricle during diastole. It's caused by various conditions that impair the closure of the aortic valve or affect the aorta itself:
Causes of chronic aortic regurgitation:
Congenital Bicuspid Valve: The most common cause in developed countries, where individuals are born with two (instead of three) aortic valve cusps, leading to earlier degeneration and dysfunction.
Rheumatic Heart Disease: The most common cause in developing countries; it can lead to valve scarring and dysfunction as a sequelae of a streptococcal infection.
Dilation of Ascending Aorta and Aortic Root: Conditions like Marfan syndrome and Ehlers-Danlos syndrome can lead to dilation, which can stretch the aortic valve ring and lead to valve incompetence.
Tertiary Syphilis: A historical cause associated with inflammation and scarring of the aortic root.
Pathophysiology of chronic aortic regurgitation:
Volume Overload: Chronic backflow into the left ventricle during diastole leads to volume overload, necessitating an increase in stroke volume to maintain cardiac output.
Compensatory Changes: The left ventricle responds with enlargement and eccentric hypertrophy (wall thickening with chamber enlargement), which can eventually progress to LV dilation and heart failure.
Clinical Features of chronic aortic regurgitation:
Often asymptomatic for many years until the compensatory mechanisms are overwhelmed.
Symptoms of Decompensation: Exertional dyspnea, angina, orthopnea (difficulty breathing when lying flat), fatigue, and syncope. Palpitations and a high pulse pressure are common, where the difference between systolic and diastolic blood pressure is unusually wide, leading to symptoms like head pounding.
Physical Examination Findings of chronic aortic regurgitation:
High Pulse Pressure: Signs include De Musset's sign (head nodding), Corrigan's sign (strong and quick pulse in the carotids), and Quincke's pulse (visible capillary pulsations in the fingernails or lips).
Diffuse, Hyperdynamic Apex Beat: Displaced inferolaterally due to the enlarged left ventricle.
S3 Gallop: This low-frequency sound is indicative of high filling pressures and volume overload in the left ventricle.
Murmurs:
Decrescendo Early Diastolic Murmur: High-pitched, best heard at Erb’s point along the left sternal border; it is indicative of the turbulent flow of blood back into the left ventricle.
Austin Flint Murmur: A rumbling, low-pitched mid-diastolic murmur heard at the apex, caused by the regurgitant jet from the aorta impacting the mitral valve, which may mimic mitral stenosis.
Diagnostics for Chronic Aortic Regurgitation:
ECG: Left axis deviation and signs of left ventricular hypertrophy are common, indicating the stress and strain on the left ventricle due to increased workload.
Echocardiography: This is the confirmatory diagnostic test and can visually assess the aortic valve's structure and function. It shows abnormalities such as thickened or malformed valve leaflets, increased left ventricular size and volume due to volume overload, and dilation of the aorta. The presence of regurgitant flow on Doppler imaging directly demonstrates the severity of aortic regurgitation.
Chest X-Ray for Chronic Aortic Regurgitation: May show an enlarged cardiac silhouette due to left ventricular hypertrophy and a prominent aortic arch, indicative of prolonged disease affecting the aorta.
Treatment for Chronic Aortic Regurgitation:
Addressing the Underlying Cause: Managing any underlying conditions such as infections that might exacerbate valve damage or addressing heart failure symptoms that might be present due to the regurgitation.
Physical Activity Recommendations: While moderate exercise can be beneficial in maintaining cardiovascular health, it should be carefully managed. Exercise decreases diastolic filling time, potentially reducing the volume of regurgitant blood returning to the left ventricle, which can help in cases where this does not exacerbate symptoms.
Aortic Valve Replacement for Chronic Aortic Regurgitation : This is recommended for patients who are symptomatic and for asymptomatic patients who have signs of significant left ventricular dysfunction (ejection fraction less than 50%) or severe left ventricular hypertrophy. Valve replacement can be performed using mechanical or biological prostheses, depending on the patient's age, comorbid conditions, and preference. Transcatheter aortic valve replacement (TAVR) may also be an option for high-risk surgical patients.
MITRAL STENOSIS
Mitral stenosis primarily results from rheumatic fever, a condition now rare in developed countries but still prevalent in places with limited access to medical care. Other causes include congenital factors, autoimmune diseases like systemic lupus erythematosus (SLE) and rheumatoid arthritis, left atrial myxoma (a non-cancerous heart tumor), infective endocarditis leading to large vegetations on the valve, and complications from degenerative aortic stenosis.
Pathophysiology: Mitral stenosis impedes the normal flow of blood from the left atrium to the left ventricle. This obstruction reduces the volume of blood filling the left ventricle during diastole, leading to a decrease in stroke volume and overall cardiac output. The result is a form of forward heart failure characterized by hypotension. Concurrently, the resistance to blood flow across the mitral valve increases left atrial pressure, which in turn causes blood to back up into the pulmonary circulation, causing symptoms of pulmonary edema and pulmonary hypertension. This is a form of backward heart failure and can contribute to the development of right ventricular hypertrophy. The increased left atrial pressure and dilation also enhance the risk of atrial fibrillation and thrombus formation due to stasis of blood in the left atrium.
Clinical Features:
Mitral stenosis typically becomes symptomatic when the valve area narrows to less than 2.5 cm², with severe symptoms manifesting when the area reduces to less than 1 cm².
Patients may remain asymptomatic for years, with symptoms often appearing about 10 years after an episode of acute rheumatic fever, usually between the ages of 20 and 30.
Common symptoms include dyspnea and orthopnea, which can be exacerbated by physical exertion, emotional stress, respiratory infections, or pregnancy.
Hemoptysis may occur due to increased pressure in the pulmonary capillaries, leading to rupture.
Hoarseness can develop from the compression of the recurrent laryngeal nerve by the enlarged left atrium.
Dysphagia, or difficulty swallowing, may result from the compression of the esophagus by the dilated left atrium.
"Mitral facies" involves pink-purple patches on the cheeks, a result of low cardiac output and peripheral vasoconstriction.
Palpitations and episodes of atrial fibrillation are common due to the dilation and increased pressure within the left atrium.
Physical Examination - Auscultation of Mitral Stenosis:
Opening Snap: This sound follows the closure of the valve and occurs due to the abrupt halt in leaflet motion during rapid filling of the left ventricle in early diastole. It's typically heard best at the 5th intercostal space at the mid-clavicular line when the patient is in the left lateral decubitus position.
Diastolic Rumble: This low-pitched sound occurs due to turbulent flow across the stenosed mitral valve during diastole and is best heard with the bell of the stethoscope.
Loud S1 (First Heart Sound): Enhanced because the mitral valve leaflets are still mobile and snap shut forcefully due to elevated left atrial pressure.
Diagnostics of Mitral Stenosis :
Electrocardiogram (ECG): Features may include P-mitrale (broad, notched P-waves indicating left atrial enlargement), atrial fibrillation (common due to left atrial dilation), and signs of right ventricular hypertrophy as a secondary effect of pulmonary hypertension.
Echocardiography: The primary tool for diagnosis, echocardiography can visualize the structural details of the mitral valve, including leaflet thickening, rigidity, calcification, subvalvular thickening, and measurement of the mitral valve area.
Chest X-ray:
Posteroanterior View: Shows left atrial enlargement and evidence of pulmonary congestion.
Lateral View: Illustrates dorsal displacement of the esophagus and signs of right ventricular hypertrophy, indicating elevated pulmonary pressures.
Treatment of Mitral Stenosis:
Conservative Management of Mitral Stenosis:
Diuretics: Used to manage symptoms of heart failure; particularly important in reducing pulmonary congestion.
Heart Rate Control: Beta-blockers or calcium channel blockers to manage heart rate, particularly in patients with atrial fibrillation.
Endocarditis Prophylaxis: Recommended for high-risk patients to prevent infective endocarditis.
ACE Inhibitors: Generally avoided due to their potential to cause hypotension by dilating peripheral vessels, which could exacerbate the condition by lowering preload.
Interventional Procedures of Mitral Stenosis:
Percutaneous Balloon Valvuloplasty (Commissurotomy): Recommended primarily for patients without significant mitral valve calcification, absence of left atrial thrombus, and minimal or no mitral regurgitation. This procedure involves dilating the stenosed valve using a balloon catheter to split the fused commissures.
Surgical Treatment of Mitral Stenosis:
Open Commissurotomy: Performed when balloon valvuloplasty is not suitable or has failed to improve valve function adequately.
Valve Replacement: Considered for patients with severely damaged valves that cannot be repaired. Valve replacement can be performed using mechanical or bioprosthetic valves depending on the patient’s age, comorbidities, and preference regarding long-term anticoagulation.
MITRAL REGURGITATION
Mitral regurgitation (MR) is a condition where the mitral valve fails to close properly during systole, allowing blood to flow backward from the left ventricle into the left atrium. This can occur due to issues directly involving the mitral valve or secondary to changes in the left ventricle. Here's an in-depth look at the causes and pathophysiology of acute MR:
Aetiology of Mitral Regurgitation
Primary Causes: Directly related to structural defects of the mitral valve:
Degenerative Mitral Valve Disease: Includes mitral valve prolapse, which is the most common form, and mitral annular calcification. Chordae tendinae may also become ruptured.
Rheumatic Fever: Leads to scarring and deformation of the valve.
Infective Endocarditis: Infections that cause damage to the valve leaflets or chordae tendinae.
Ischemic Disease: Particularly due to papillary muscle rupture following an acute myocardial infarction, which affects the valve's ability to close.
Secondary Causes of Mitral Regurgitation: Resulting from changes in the structure or function of the left ventricle:
Coronary Artery Disease: May cause dysfunction or rupture of the papillary muscles.
Dilated Cardiomyopathy and Left-Sided Heart Failure: These conditions can lead to functional mitral regurgitation due to the dilation of the left ventricle.
Acute Mitral Regurgitation
Acute MR occurs when there is sudden dysfunction of the mitral valve, leading to immediate and severe consequences:
Causes: Can include acute endocarditis, ischemic papillary muscle dysfunction or rupture, complications from aortic dissection type A, or direct chest trauma.
Pathophysiology: The sudden regurgitation of blood into the left atrium increases its pressure and volume significantly, leading to rapid pulmonary congestion and edema. This acute increase in left atrial pressure can overwhelm the pulmonary vasculature, causing fluid to leak into the alveoli, resulting in pulmonary edema.
Symptoms of acute mitral regurgitation: Patients may experience severe dyspnea (difficulty breathing), hypotension (low blood pressure), and tachycardia (rapid heartbeat). Signs of left-sided heart failure are prominent, including pulmonary edema, which may progress to cardiogenic shock if not promptly treated.
CHRONIC MITRAL REGURGITATION
Chronic mitral regurgitation (MR) is a progressive condition where the mitral valve does not close fully, allowing blood to flow back into the left atrium from the left ventricle during systole. This leads to volume and pressure overload in the left atrium and ventricle, initiating a series of compensatory changes and eventually resulting in heart failure.
Causes of chronic mitral regurgitation
Bicuspid Aortic Valve: Can lead to mitral valve problems due to associated abnormalities in the heart's structure.
Connective Tissue Diseases: Such as Marfan syndrome, which can affect the integrity of the heart valves.
Rheumatic Fever: Causes chronic damage to the mitral valve, leading to stenosis or regurgitation.
Pathophysiology of chronic mitral regurgitation
Eccentric Hypertrophy: The left ventricle initially adapts by undergoing eccentric hypertrophy to handle the increased volume. This increases the end-diastolic volume to maintain a normal ejection fraction.
Progression to Heart Failure: Over time, the continuous volume overload leads to ventricular enlargement and myocardial dysfunction. As the stroke volume decreases, pressure builds up in the left ventricle and atrium, causing pulmonary congestion and potential atrial fibrillation.
Symptoms of chronic mitral regurgitation
Patients might be asymptomatic for years despite the progressive nature of the disease.
Symptoms when they do appear include palpitations, dyspnea (which can be exertional, nocturnal, or cause a dry cough), fatigue, and other symptoms typical of left-sided heart failure.
Physical Examination of chronic mitral regurgitation
Acute Presentation: The murmur may be soft and decrescendo; in severe cases with left ventricular dysfunction or hypotension, the murmur may not be present.
Chronic Presentation:
Apex Beat: Lateral displacement of the apex beat due to left ventricular hypertrophy.
Murmur: A holosystolic, high-pitched blowing murmur heard best in the 5th intercostal space at the left midclavicular line, radiating to the left axilla. This murmur’s intensity increases with maneuvers that increase preload (like leg raise) or afterload (like handgrip or squatting), which heighten the regurgitant flow.
S1: Often quieter due to the impaired closure of the mitral leaflets.
S3: May be present in advanced disease, indicating ventricular volume overload.
Diagnostics of chronic mitral regurgitation:
Electrocardiogram (ECG):
Acute Settings: The ECG might show non-specific changes such as sinus tachycardia, signs of acute ischemia, or atrial fibrillation.
Chronic Settings: Features on ECG can include evidence of left ventricular hypertrophy (LVH) due to the increased workload on the heart, P-mitrale reflecting left atrial enlargement, atrial fibrillation due to atrial dilation and fibrosis, and in later stages, signs of right heart strain like P-pulmonale.
Echocardiography of chronic mitral regurgitation: This is the primary diagnostic tool showing the dysfunctional valve movement, dilated left atrium, remodeled ventricle, and in advanced cases, increased pulmonary artery pressures.
X-ray of chronic mitral regurgitation: For chronic cases, an X-ray can reveal left ventricular enlargement (indicated by a laterally displaced left cardiac border), left atrial enlargement (noted as straightening of the left heart border and a double contour of the right atrial border), and signs of pulmonary congestion in decompensated disease.
Treatment of chronic mitral regurgitation:
Surgical Interventions of chronic mitral regurgitation:
Valvuloplasty or Valve Replacement: Indicated for symptomatic patients or those with a reduced left ventricular ejection fraction to restore normal valve function and alleviate symptoms.
Mitraclip: A less invasive procedure where a clip is inserted via catheter to "glue" the mitral valve cusps together, reducing regurgitation.
Pharmacological Management of chronic mitral regurgitation:
Vasodilators and Diuretics: To reduce preload and alleviate symptoms of congestion.
Digoxin: Used particularly in patients with atrial fibrillation to control heart rate.
ACE Inhibitors and Beta-blockers: To manage blood pressure, reduce heart strain, and improve heart function.
Endocarditis Prophylaxis: Recommended for patients at high risk of bacterial endocarditis due to valve replacement or existing valve damage.
MITRAL VALVE PROLAPSE
Mitral valve prolapse (MVP) is a condition where the mitral valve leaflets improperly bulge (prolapse) into the left atrium during the heart's contraction phase (systole). This valvular abnormality is frequently seen in clinical practice and is a prevalent cause of mitral regurgitation.
Pathophysiology of Mitral valve prolapse (MVP):
Myxomatous Degeneration: This is the primary pathological process in MVP, characterized by an accumulation of glycosaminoglycans within the valve structure. This results in:
Elongation and thickening of the mitral valve leaflets.
Dilation of the mitral valve annulus.
Lengthening of the chordae tendineae.
Severe Cases of Mitral valve prolapse: If the supporting structures like papillary muscles become ischemic or if there is a rupture of the chordae tendineae, the leaflets may flail back into the left atrium more dramatically, leading to significant mitral regurgitation.
Clinical Features of Mitral valve prolapse (MVP):
Asymptomatic Presentation: Many individuals with MVP do not experience symptoms and the condition may only be discovered incidentally during a routine examination or echocardiographic study.
Audible Murmur: The classic auscultatory finding in MVP is a midsystolic click, caused by the sudden tensing of the elongated chordae tendineae as the valve leaflets prolapse. This click is often followed by a mid-to-late systolic crescendo murmur if mitral regurgitation is present. This murmur is most pronounced at the 5th intercostal space along the midaxillary line on the left side of the chest.
Chest Pain and Anxiety of Mitral valve prolapse (MVP):: While many cases are symptom-free, some individuals may report chest pain that does not typically resemble angina pectoris associated with coronary artery disease. Anxiety is another non-specific symptom that some patients attribute to their cardiac condition, although the relationship is not clearly understood.
Diagnostics of Mitral Valve Prolapse:
Electrocardiogram (ECG): Usually normal, may show minor abnormalities if there are related arrhythmias or other cardiac effects.
Transthoracic Echocardiography: This is the confirmatory test for diagnosing mitral valve prolapse. The diagnosis is made when there is displacement of one or both mitral valve leaflets by more than 2 mm above the plane of the mitral valve annulus into the left atrium during systole.
Treatment of Mitral Valve Prolapse:
General Approach: Treatment is typically conservative unless the mitral valve prolapse progresses to severe mitral regurgitation, at which point more active interventions may be required.
Other Valves - Tricuspid Valve:
Stenosis of Tricuspid Valve :
Causes: Rare condition, often due to rheumatic fever or, in IV drug users, infective endocarditis.
Symptoms: Can lead to low cardiac output manifesting as fatigue, and abdominal discomfort due to hepatomegaly or ascites due to fluid accumulation.
Murmur: Characterized by a delayed diastolic murmur with a decrescendo quality, best heard in the 4th intercostal space to the left of the sternum, increasing in intensity during inspiration.
Treatment: Conservative management includes salt restriction and diuretics; surgical intervention may be necessary in cases of severe stenosis.
Regurgitation of Tricuspid Valve :
Causes: May be caused by right ventricular dilation, infective endocarditis, rheumatic fever, connective tissue diseases, or carcinoid syndrome.
Symptoms: Manifestations of reduced cardiac output such as ascites, congestive hepatomegaly, and peripheral edema.
Murmur: A holosystolic murmur heard at the left sternal edge, which increases in intensity during deep inspiration.
Treatment: In severe cases, tricuspid valve replacement may be considered.
Pulmonary Valve Issues
Stenosis of Pulmonary Valve:
Nature: Mostly congenital. Severe cases can lead to right ventricular (RV) failure, and patients are at increased risk for infective endocarditis.
Murmur: Characterized by a systolic ejection crescendo-decrescendo murmur, best heard in the 2nd intercostal space parasternally on the left, and it may radiate to the back.
Prognosis: Survival into adulthood is common, but complications such as RV failure and infective endocarditis can occur.
Regurgitation of Pulmonary Valve :
Causes: Often secondary to conditions like pulmonary hypertension (e.g., in tetralogy of Fallot) or resulting from dilated cardiomyopathy.
Murmur: Early diastolic decrescendo murmur best heard at the left sternal edge, intensified by deep inspiration.
Clinical Impact: Symptoms of the primary disease generally overshadow those of pulmonary regurgitation; surgical intervention is rarely needed unless the regurgitation is severe.
PROSTETHIC VALVES
Mechanical Valves:
Durability: Very high, but they require long-term anticoagulation therapy (e.g., warfarin) to prevent valve thrombosis and reduce the risk of systemic embolism.
Complications: Anticoagulant-related bleeding, valve thrombosis, and potential mild hemolysis.
Biological Valves:
Durability: Less durable than mechanical valves, with a higher likelihood of valve-related failure over time.
Post-implantation Care: Requires anticoagulation therapy only for the first three months post-surgery; patients may switch to aspirin thereafter if they maintain sinus rhythm.
Preferred Patient Demographic: Often recommended for elderly patients due to the limited durability and lesser need for long-term anticoagulation.
ECHOCARDIOGRAPHY
Echocardiography is a versatile, non-invasive diagnostic tool that utilizes ultrasound waves to create images of the heart. The sound waves pass through body tissues and reflect back to the device, providing detailed images of the heart's structure and function. Here's an overview of the different types of echocardiography and their specific uses:
M-mode Echocardiography:
Purpose: Primarily used to measure the heart's structures, such as wall thickness and the movement of heart valves.
Detail: Offers high temporal resolution which is great for assessing the timing of cardiac events.
2-dimensional (2D) Echocardiography:
Purpose: Provides a real-time image of the heart, allowing for the evaluation of cardiac anatomy and motion.
Applications: Useful for assessing wall motion abnormalities, valve function, and the presence of intracardiac masses like thrombi or tumors.
Doppler Echocardiography:
Purpose: Utilizes the Doppler effect to measure and assess the flow of blood through the heart's chambers and valves.
Details: Can detect abnormal blood flow within the heart, which is useful for identifying stenosis or insufficiencies in valves.
Color Flow Doppler:
Purpose: Provides a color-coded image of the flow of blood through the heart which helps to visualize the speed and direction of blood flow.
Applications: Particularly helpful in diagnosing valvular problems and shunts.
Transthoracic Echocardiography (TTE):
Purpose: The most common type, performed by placing the transducer on the chest wall to obtain heart images.
Uses: Assesses overall heart function, detects abnormalities, and measures the size and shape of the heart's chambers.
Transesophageal Echocardiography (TEE):
Purpose: Provides more detailed and clearer images of the heart, especially the posterior structures like the atria, valves, and aorta.
Procedure: Involves inserting the probe via the esophagus, closer to the heart without interference from the ribs or lungs.
3-dimensional (3D) Echocardiography:
Purpose: Offers a more precise and comprehensive view of the heart's anatomy and pathology.
Applications: Extremely beneficial for assessing complex valvular abnormalities and congenital heart disease.
Contrast Echocardiography:
Purpose: Enhances the echocardiography images by using intravenous contrast agents that reflect ultrasound waves better than blood or tissues.
Uses: Helpful in identifying and characterizing abnormal cardiac shunts and improving the delineation of the heart's structures.